Stability of antimycobacterial drugs in susceptibility testing
about
Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium aviumA point mutation in cycA partially contributes to the D-cycloserine resistance trait of Mycobacterium bovis BCG vaccine strainsMulticenter laboratory validation of susceptibility testing of Mycobacterium tuberculosis against classical second-line and newer antimicrobial drugs by using the radiometric BACTEC 460 technique and the proportion method with solid media.Detection of first- and second-line drug resistance in Mycobacterium tuberculosis clinical isolates by pyrosequencing.Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: study of antibiotic combinationsFighting an old disease with modern tools: characteristics and molecular detection methods of drug-resistant Mycobacterium tuberculosis.Dose selection and pharmacokinetics of rifampin in elephants for the treatment of tuberculosis.Validation of the use of Middlebrook 7H10 agar, BACTEC MGIT 960, and BACTEC 460 12B media for testing the susceptibility of Mycobacterium tuberculosis to levofloxacin.Antimycobacterial susceptibility testing: present practices and future trends.Rifampin stability in 7H9 broth and Löwenstein-Jensen medium.In vitro drug susceptibility of Mycobacterium tuberculosis for amikacin, kanamycin and capreomycin.Simultaneous drug resistance detection and genotyping of Mycobacterium tuberculosis using a low-density hydrogel microarray.
P2860
Q28378889-7DF91262-4ED8-40A6-8608-140201298BE1Q28482347-D9AF2E2E-CB30-4C76-B7D3-164304DBFCBAQ33962909-9C9476E5-224E-4703-8CA6-473EC7589629Q36022970-81110D9A-D135-4819-A5E2-D45B5035B3A8Q37144883-880E4ACD-E357-451C-84E2-2B16E406DF6CQ38545953-916C6B90-0940-4D93-AB2D-77274A1F7B9CQ38700929-6FEDF01E-3B02-4644-8B12-F4213130900EQ40279724-435F1E3F-2DFD-4DAC-9BD8-E1F467373CA4Q40494966-1834A731-08FE-443F-9966-45DD9846F828Q42706954-802ED05D-7F2B-4642-988D-3D867B4CE814Q50134142-A529174A-55B2-4212-A7DA-470FC444401FQ53221993-8227A16C-DF45-4FCF-95FC-C292E18CE152
P2860
Stability of antimycobacterial drugs in susceptibility testing
description
1992 nî lūn-bûn
@nan
1992 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Stability of antimycobacterial drugs in susceptibility testing
@ast
Stability of antimycobacterial drugs in susceptibility testing
@en
type
label
Stability of antimycobacterial drugs in susceptibility testing
@ast
Stability of antimycobacterial drugs in susceptibility testing
@en
prefLabel
Stability of antimycobacterial drugs in susceptibility testing
@ast
Stability of antimycobacterial drugs in susceptibility testing
@en
P2860
P356
P1476
Stability of antimycobacterial drugs in susceptibility testing
@en
P2093
Griffith ME
P2860
P304
P356
10.1128/AAC.36.11.2398
P407
P577
1992-11-01T00:00:00Z